Ignite Creation Date:
2025-12-24 @ 2:56 PM
Ignite Modification Date:
2026-01-02 @ 6:33 AM
Study NCT ID:
NCT03501459
Status:
RECRUITING
Last Update Posted:
2019-08-28
First Post:
2018-04-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lymphocyte Markers As Predictors Of Responsiveness To Rituximab Among Patients With Idiopathic Nephrotic Syndrome
Sponsor:
National University Health System, Singapore
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NMRC/NIG/0026/2008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None